2P30-CA16672/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1995	1
1996	1
1997	1
1998	3
1999	2
2000	1
2001	1
2002	1
2004	1
2024	0

1

Brown PH, Lippman SM. Brown PH, et al. Breast Cancer Res Treat. 2000 Jul;62(1):1-17. doi: 10.1023/a:1006484604454. Breast Cancer Res Treat. 2000. PMID: 10989982 Review.

2

Alternative RNA processing--its role in regulating expression of calcitonin/calcitonin gene-related peptide.

Lou H, Gagel RF. Lou H, et al. J Endocrinol. 1998 Mar;156(3):401-5. doi: 10.1677/joe.0.1560401. J Endocrinol. 1998. PMID: 9582495 Review.

3

Alternative ribonucleic acid processing in endocrine systems.

Lou H, Gagel RF. Lou H, et al. Endocr Rev. 2001 Apr;22(2):205-25. doi: 10.1210/edrv.22.2.0426. Endocr Rev. 2001. PMID: 11294824

4

Evidence supporting a role for calcium in apoptosis induction by the synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO).

Hail N Jr, Konopleva M, Sporn M, Lotan R, Andreeff M. Hail N Jr, et al. J Biol Chem. 2004 Mar 19;279(12):11179-87. doi: 10.1074/jbc.M312758200. Epub 2004 Jan 7. J Biol Chem. 2004. PMID: 14711815 Free article.

5

An intron enhancer recognized by splicing factors activates polyadenylation.

Lou H, Gagel RF, Berget SM. Lou H, et al. Genes Dev. 1996 Jan 15;10(2):208-19. doi: 10.1101/gad.10.2.208. Genes Dev. 1996. PMID: 8566754 Free article.

6

An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene.

Lou H, Yang Y, Cote GJ, Berget SM, Gagel RF. Lou H, et al. Mol Cell Biol. 1995 Dec;15(12):7135-42. doi: 10.1128/MCB.15.12.7135. Mol Cell Biol. 1995. PMID: 8524281 Free PMC article.

7

Regulation of alternative polyadenylation by U1 snRNPs and SRp20.

Lou H, Neugebauer KM, Gagel RF, Berget SM. Lou H, et al. Mol Cell Biol. 1998 Sep;18(9):4977-85. doi: 10.1128/MCB.18.9.4977. Mol Cell Biol. 1998. PMID: 9710581 Free PMC article.

8

Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon.

Lou H, Helfman DM, Gagel RF, Berget SM. Lou H, et al. Mol Cell Biol. 1999 Jan;19(1):78-85. doi: 10.1128/MCB.19.1.78. Mol Cell Biol. 1999. PMID: 9858533 Free PMC article.

9

Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.

Andersson BS, Thall PF, Madden T, Couriel D, Wang X, Tran HT, Anderlini P, de Lima M, Gajewski J, Champlin RE. Andersson BS, et al. Biol Blood Marrow Transplant. 2002;8(9):477-85. doi: 10.1053/bbmt.2002.v8.pm12374452. Biol Blood Marrow Transplant. 2002. PMID: 12374452 Free article. Clinical Trial.

10

Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 alpha-exon recognition in glioblastoma cells.

Jin W, Huang ES, Bi W, Cote GJ. Jin W, et al. J Biol Chem. 1999 Sep 24;274(39):28035-41. doi: 10.1074/jbc.274.39.28035. J Biol Chem. 1999. PMID: 10488155 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year